Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial

Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects

(2012) Donghoon Shin et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

(2012) A. Neumann et al.   DIABETOLOGIA

Thiazolidinediones and PPARγ agonists: time for a reassessment

(2012) Bertrand Cariou et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects

(2011) Jung Won Kim et al.   CLINICAL THERAPEUTICS

Rosiglitazone Revisited

(2010) Steven E. Nissen et al.   ARCHIVES OF INTERNAL MEDICINE

Potential remains for PPAR-targeted drugs

(2010) Dan Jones   NATURE REVIEWS DRUG DISCOVERY